2008
An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: A meta-analysis of contemporary randomized controlled trials
Wijeysundera HC, You JJ, Nallamothu BK, Krumholz HM, Cantor WJ, Ko DT. An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: A meta-analysis of contemporary randomized controlled trials. American Heart Journal 2008, 156: 564-572.e2. PMID: 18760142, DOI: 10.1016/j.ahj.2008.04.024.Peer-Reviewed Original ResearchMeSH KeywordsAngioplasty, Balloon, CoronaryCardiac CatheterizationElectrocardiographyFemaleFibrinolytic AgentsHemorrhageHumansInjections, IntravenousInpatientsMaleMiddle AgedMyocardial InfarctionMyocardial IschemiaMyocardial ReperfusionRandomized Controlled Trials as TopicRecurrenceStentsStrokeThrombolytic TherapyConceptsST-segment elevation myocardial infarctionEarly invasive strategyPercutaneous coronary interventionElevation myocardial infarctionFibrinolytic therapyInvasive strategyMajor bleedingSTEMI patientsMyocardial infarctionHospital major bleedingIntravenous fibrinolytic therapyLarge randomized trialsRisk of strokeSignificant reductionCause mortalityEligible trialsCoronary interventionRandomized trialsContemporary trialsStent useInclusion criteriaPatientsReinfarctionTherapyTrials
1999
Under-Utilisation of b-Blockers After Acute Myocardial Infarction
Bradford W, Chen J, Krumholz H. Under-Utilisation of b-Blockers After Acute Myocardial Infarction. PharmacoEconomics 1999, 15: 257-268. PMID: 10537433, DOI: 10.2165/00019053-199915030-00005.Peer-Reviewed Original ResearchConceptsB-blocker therapyB-blockersAcute myocardial infarction survivorsRelative risk reductionAcute myocardial infarctionMyocardial infarction survivorsLess effective treatmentsFirst yearHospital readmissionMyocardial infarctionInfarction survivorsDearth of evidenceEffective treatmentTherapyMedical resourcesRisk reductionHealth statesRecent studiesLittle evidenceAMIUnderprescriptionReinfarctionReadmissionMorbidityInfarction